Cancer
OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
Published in Cancer Weekly, October 13th, 2009
Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) announced that, in a study from Brown University to be presented by Howard Safran, M.D., head of the Brown University Oncology Group, in the proffered oral session at the Annual Meeting of the International Society of Gastrointestinal Oncology (ISGIO) in Philadelphia, Pennsylvania patients with cancer of the lower esophagus demonstrated a high rate of complete remission (CR) when given OPAXIO™ (paclitaxel poliglumex), a biologically enhanced paclitaxel, when administered in combination with standard cisplatin and concurrent radiation.
The phase II study, led by Dr. Safran, enrolled 40 patients with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-10-13)
More Articles from Cancer Weekly
- Cancer Gene Therapy
New cancer gene therapy research has been reported by H. Maeda et al - Cancer Gene Therapy
Reports outline cancer gene therapy study findings from S. Terao and colleagues - Cancer Gene Therapy
Research reports from E.M. Glinka and co-authors provide new insights into cancer gene therapy - Cancer Gene Therapy
Researchers from University of Buenos Aires publish new studies and findings in the area of cancer gene therapy - Cancer Vaccines
Findings from M. Adamopoulou and co-authors provide new insights into cancer vaccines - Cancer Vaccines
New cancer vaccines research from F.M. Lemoine and co-researchers described - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
